Morgan Keegan Maintains Outperform on Trustmark (TRMK)

Morgan Keegan is out with its report today on Trustmark TRMK, maintaining Outperform. In a note to clients, Morgan Keegan writes, "We would be buyers of TRMK at current levels as first quarter results reaffirm our view, that led by a top quality and conservative management team, this franchise is well positioned to deploy its excess capital toward pursuing organic as well as M&A opportunities over the coming months/quarters." Morgan Keegan has a $27 PT on TRMK. At the time of posting, shares of TRMK were at $23.55, up 0.77% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsFinancialsMorgan KeeganRegional Bankstrustmark
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!